{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:45:14Z","timestamp":1790801114873,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010531","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T00:00:00Z","timestamp":1471478400000}}],"reference-count":56,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010531.pub2","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T04:45:49Z","timestamp":1471495549000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants"],"prefix":"10.1002","volume":"2016","author":[{"given":"Kiran","family":"More","sequence":"first","affiliation":[{"name":"Christchurch Women's Hospital; Department of Neonatology; Canterbury New Zealand"},{"name":"University of Otago; Dunedin New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri K","family":"Athalye-Jape","sequence":"additional","affiliation":[{"name":"Princess Margaret Hospital and King Edward Hospital; Department of Neonatology; Roberts Road Subiaco Western Australia Australia 6008"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shripada C","family":"Rao","sequence":"additional","affiliation":[{"name":"King Edward Memorial Hospital for Women and Princess Margaret Hospital for Children; Centre for Neonatal Research and Education; Perth, Western Australia Australia 6008"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K","family":"Patole","sequence":"additional","affiliation":[{"name":"King Edward Memorial Hospital; School of Paediatrics and Child Health, School of Women's and Infant's Health, University of Western Australia; 374 Bagot Rd Subiaco Perth Western Australia Australia 6008"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,8,18]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD010531.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/jp.2011.157","article-title":"A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn","volume":"32","author":"Mohamed","year":"2012","journal-title":"Journal of Perinatology"},{"key":"10.1002\/14651858.CD010531.pub2-BIB0002|cit2","unstructured":"NCT01389856: Persistent Pulmonary Hypertension of the Newborn (FUTURE 4) https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT01389856?sect=X01256#all"},{"key":"10.1002\/14651858.CD010531.pub2-BIB0003|cit3","unstructured":"Steinhorn R Kusic-Pajic A Cornelisse P Fineman J Gehin M Nowbakht P Bosentan as adjunctive therapy for persistent pulmonary hypertension of the newborn: Results of the FUTURE-4 study Circulation: American Heart Association's 2014 Scientific Sessions and Resuscitation Science Symposium Chicago, IL United States 2014"},{"issue":"4","key":"10.1002\/14651858.CD010531.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000101343","article-title":"Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn","volume":"91","author":"Abman","year":"2007","journal-title":"Neonatology"},{"key":"10.1002\/14651858.CD010531.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev.med.59.110106.212434","article-title":"Role of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension","volume":"60","author":"Abman","year":"2009","journal-title":"Annual Review of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010531.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1164\/ajrccm\/148.2.519","article-title":"Circulating immunoreactive\u00a0endothelin-1 in children with\u00a0pulmonary hypertension. Association with acute hypoxic\u00a0pulmonary\u00a0vasoreactivity","volume":"148","author":"Allen","year":"1993","journal-title":"American Review of Respiratory Disease"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD010531.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1203\/01.PDR.0000159512.55862.69","article-title":"Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling","volume":"57","author":"Ambalavanan","year":"2005","journal-title":"Pediatric Research"},{"issue":"8","key":"10.1002\/14651858.CD010531.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1139\/Y08-059","article-title":"Endothelin: 20 years from discovery to therapy","volume":"86","author":"Barton","year":"2008","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD010531.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/157016109787455653","article-title":"Bosentan in pediatric patients with pulmonary arterial hypertension","volume":"7","author":"Beghetti","year":"2009","journal-title":"Current Vascular Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD010531.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ppul.20201","article-title":"Pathophysiologic mechanisms of persistent pulmonary hypertension of the newborn","volume":"39","author":"Dakshinamurti","year":"2005","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD010531.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/3-540-32967-6_9","article-title":"Endothelin","volume":"176 Pt 1","author":"Davenport","year":"2006","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD010531.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/path.1677","article-title":"Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia","volume":"205","author":"Lagausie","year":"2005","journal-title":"Journal of Pathology"},{"issue":"3","key":"10.1002\/14651858.CD010531.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"F223","DOI":"10.1136\/adc.2009.180091","article-title":"The management of neonatal pulmonary hypertension","volume":"97","author":"Dhillon","year":"2012","journal-title":"Archives of Diseases in Childhood. Fetal and Neonatal Edition"},{"key":"10.1002\/14651858.CD010531.pub2-BIB0014|cit14","unstructured":"Drinker LR Cotten CM Rattray BN Hornik CD Smith PB Goldberg RN Bosentan in Neonatal Patients with Pulmonary Hypertension E-PAS2012 2012"},{"issue":"7109","key":"10.1002\/14651858.CD010531.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD010531.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/PL00008431","article-title":"Endogenous nitric oxide and\u00a0endothelin-1 in persistent pulmonary hypertension of the newborn","volume":"160","author":"Endo","year":"2001","journal-title":"European Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD010531.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cardiores.2003.11.026","article-title":"The endothelin system in pulmonary arterial hypertension","volume":"61","author":"Gali\u00e8","year":"2004","journal-title":"Cardiovascular Research"},{"issue":"1","key":"10.1002\/14651858.CD010531.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1203\/01.pdr.0000191813.60977.bf","article-title":"Tezosentan decreases pulmonary artery pressure and improves survival rate in an animal model of meconium aspiration","volume":"59","author":"Geiger","year":"2006","journal-title":"Pediatric Research"},{"issue":"2","key":"10.1002\/14651858.CD010531.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00134-007-0857-y","article-title":"Intravenous tezosentan improves gas exchange and hemodynamics in acute lung injury secondary to meconium aspiration","volume":"34","author":"Geiger","year":"2008","journal-title":"Intensive Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010531.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0095-5108(18)30899-6","article-title":"Neonatal pulmonary hypertension: pathophysiology, classification, and etiology","volume":"11","author":"Gersony","year":"1984","journal-title":"Clinics in Perinatology"},{"issue":"24","key":"10.1002\/14651858.CD010531.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010531.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00431-007-0531-y","article-title":"Persistent pulmonary hypertension of the newborn with transposition of the great arteries: successful treatment with bosentan","volume":"167","author":"Goissen","year":"2008","journal-title":"European Journal of Pediatrics"},{"key":"10.1002\/14651858.CD010531.pub2-BIB0023|cit23","unstructured":"McMaster University GRADEpro [www.gradepro.org] 2014"},{"key":"10.1002\/14651858.CD010531.pub2-BIB0024|cit24","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions\u00a0Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD010531.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jtcvs.2010.03.023","article-title":"Bosentan induces clinical and hemodynamic improvement in candidates for right-sided heart bypass surgery","volume":"140","author":"Hirono","year":"2010","journal-title":"Journal of Thoracic and Cardiovascular Surgery"},{"issue":"12","key":"10.1002\/14651858.CD010531.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1185\/030079906X158020","article-title":"Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition?","volume":"22","author":"Jacobs","year":"2006","journal-title":"Current medical research and opinion"},{"issue":"3","key":"10.1002\/14651858.CD010531.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.pcl.2009.04.004","article-title":"Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn","volume":"56","author":"Konduri","year":"2009","journal-title":"Pediatric Clinics of North America"},{"issue":"6","key":"10.1002\/14651858.CD010531.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s00246-008-9260-x","article-title":"Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies","volume":"29","author":"Krishnan","year":"2008","journal-title":"Pediatric Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD010531.pub2-BIB0029|cit29","first-page":"420","article-title":"Endothelin-A receptor antagonist prevents neonatal pulmonary hypertension in meconium aspiration in piglets","volume":"100","author":"Kuo","year":"2001","journal-title":"Journal of the Formosan Medical Association"},{"issue":"5","key":"10.1002\/14651858.CD010531.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1995.tb02008.x","article-title":"Endothelin-1 and the regulation of vascular tone","volume":"22","author":"La","year":"1995","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"3","key":"10.1002\/14651858.CD010531.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0095-5108(18)30039-3","article-title":"Pulmonary vascular biology during neonatal transition","volume":"26","author":"Lakshminrusimha","year":"1999","journal-title":"Clinics in Perinatology"},{"issue":"5 Pt 2","key":"10.1002\/14651858.CD010531.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"21R","DOI":"10.1203\/01.PDR.0000159575.58834.8D","article-title":"Developmental expression of vasoactive and growth factors in human lung. Role in pulmonary vascular resistance adaptation at birth","volume":"57","author":"Levy","year":"2005","journal-title":"Pediatric Research"},{"issue":"2","key":"10.1002\/14651858.CD010531.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1203\/01.PDR.0000148280.86670.7B","article-title":"Developmental changes in endothelial vasoactive and angiogenic growth factors in the human perinatal lung","volume":"57","author":"Levy","year":"2005","journal-title":"Pediatric Research"},{"issue":"2","key":"10.1002\/14651858.CD010531.pub2-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004434.pub5","article-title":"Endothelin receptor antagonists for pulmonary arterial hypertension","author":"Liu","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"19","key":"10.1002\/14651858.CD010531.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/01.CIR.102.19.2434","article-title":"Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs","volume":"102","author":"Luscher","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD010531.pub2-BIB0036|cit36","unstructured":"Moussa A Lavoie J Barrington KJ Bosentan for Secondary Pulmonary Arterial Hypertension in Neonates: A Case Series E-PAS201129 2011"},{"issue":"10","key":"10.1002\/14651858.CD010531.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1651-2227.2009.01386.x","article-title":"Successful treatment of persistent pulmonary hypertension of the newborn with bosentan","volume":"98","author":"Nakwan","year":"2009","journal-title":"Acta Paediatrica, International Journal of Paediatrics"},{"issue":"6","key":"10.1002\/14651858.CD010531.pub2-BIB0038|cit38","first-page":"453","article-title":"An initial experience of endotherine-1 dual-receptor blockade in the treatment of sustained pulmonary hypertension early after congenital cardiac surgery in infancy","volume":"60","author":"Nemoto","year":"2007","journal-title":"Kyobu Geka. The Japanese Journal of Thoracic Surgery"},{"issue":"9","key":"10.1002\/14651858.CD010531.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrcardio.2011.104","article-title":"Treatment of pulmonary arterial hypertension with targeted therapies","volume":"8","author":"O'Callaghan","year":"2011","journal-title":"Nature Reviews. Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD010531.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4187\/respcare.01297","article-title":"Advances in the management of pediatric pulmonaryhypertension","volume":"56","author":"Oishi","year":"2011","journal-title":"Respiratory Care"},{"issue":"5","key":"10.1002\/14651858.CD010531.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1714-21; discus","DOI":"10.1016\/S0003-4975(99)00988-1","article-title":"Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function","volume":"68","author":"Pearl","year":"1999","journal-title":"Annals of Thoracic Surgery"},{"key":"10.1002\/14651858.CD010531.pub2-BIB0042|cit42","unstructured":"Peng J Ladino J Hehre D Bancalari E Suguihara E Effects of a selective endothelin A (ETA) receptor antagonist on GBS-induced pulmonary hypertension in newborn piglets Pediatric Academic Societies\u2019 Annual Meeting 2003"},{"issue":"4","key":"10.1002\/14651858.CD010531.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/SHK.0b013e31819e2cbb","article-title":"Inhaled tezosentan reduces pulmonary hypertension in endotoxin-induced lung injury","volume":"32","author":"Persson","year":"2009","journal-title":"Shock"},{"issue":"8","key":"10.1002\/14651858.CD010531.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00431-011-1422-9","article-title":"Combination therapy for life-threatening pulmonary hypertension in a premature infant: First report on bosentan use","volume":"170","author":"Radicioni","year":"2011","journal-title":"European Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD010531.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1586\/erc.09.186","article-title":"Current and future therapeutic options for persistent pulmonary hypertension in the newborn","volume":"8","author":"Rao","year":"2010","journal-title":"Expert Review of Cardiovascular Therapy"},{"issue":"9","key":"10.1002\/14651858.CD010531.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199702273360902","article-title":"Inhaled\u00a0nitric\u00a0oxide\u00a0and persistent pulmonary hypertension of the newborn. The\u00a0Inhaled\u00a0Nitric\u00a0Oxide\u00a0Study Group","volume":"336","author":"Roberts","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010531.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0022-3476(05)81552-5","article-title":"Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension","volume":"123","author":"Rosenberg","year":"1993","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD010531.pub2-BIB0048|cit48","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A GRADE Working Group GRADE handbook for grading quality of evidence and strength of recommendations Available from www.guidelinedevelopment.org\/handbook Updated October 2013"},{"issue":"8","key":"10.1002\/14651858.CD010531.pub2-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005494.pub3","article-title":"Sildenafil for pulmonary hypertension in neonates","author":"Shah","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010531.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.phrs.2011.03.003","article-title":"The role of\u00a0endothelin-1\u00a0in the pathogenesis of\u00a0pulmonary\u00a0arterial\u00a0hypertension","volume":"63","author":"Shao","year":"2011","journal-title":"Pharmacological Research"},{"issue":"3","key":"10.1002\/14651858.CD010531.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00383-010-2668-4","article-title":"Acute effect of a dual ETA-ETB receptor antagonist on pulmonary arterial vasculature in preterm lamb fetuses with surgically induced diaphragmatic hernia","volume":"27","author":"Stathopoulos","year":"2011","journal-title":"Pediatric Surgery International"},{"issue":"3","key":"10.1002\/14651858.CD010531.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bpa.2010.02.021","article-title":"Pulmonary hypertension of the newborn","volume":"24","author":"Stayer","year":"2010","journal-title":"Best Practice and Research Clinical Anaesthesiology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD010531.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/PCC.0b013e3181c76cdc","article-title":"Neonatal pulmonary hypertension","volume":"11","author":"Steinhorn","year":"2010","journal-title":"Pediatric Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010531.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0735-1097(03)00556-4","article-title":"Hemodynamic and clinical effects of tezosentan, an intravenous dual\u00a0endothelin receptor\u00a0antagonist, in patients hospitalized for acute decompensated heart failure","volume":"42","author":"Torre-Amione","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD010531.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"6163","key":"10.1002\/14651858.CD010531.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa\u00a0M","year":"1988","journal-title":"Nature"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010531.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T07:22:56Z","timestamp":1718781776000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010531.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neonatal Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,18]]},"references-count":56,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010531.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,18]]}}}